Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1986 Feb;61(2):130–137. doi: 10.1136/adc.61.2.130

Neurological aspects of biopterin metabolism.

I Smith, R J Leeming, N P Cavanagh, K Hyland
PMCID: PMC1777602  PMID: 3954438

Abstract

Plasma total biopterin concentration was measured by bioassay in 59 infants with hyperphenylalaninaemia and in 50 children with developmental regression and or movement disorder with normal plasma phenylalanine concentrations. In infants with raised phenylalanine concentrations plasma biopterin concentrations were significantly raised in proportion to the phenylalanine values. Five patients had plasma biopterin concentrations at the extremes of the range, and of these two had defective biopterin metabolism. One with low plasma biopterin concentration apparently had a partial defect of biopterin synthesis but died before investigations were complete. One with high plasma biopterin concentration, even when phenylalanine concentrations had fallen to the normal range, had dihydropteridine reductase deficiency. In this patient concentrations of homovanillic acid and 5-hydroxyindolacetic acid in the cerebrospinal fluid (CSF) were severely reduced. In children without hyperphenylalaninaemia plasma biopterin concentrations were normal. Twenty two patients were subjected to lumbar puncture, of whom six with developmental regression without movement disorder had normal CSF biopterin concentrations, and 11 with movement disorder other than torsion dystonia had significantly lower CSF biopterin concentrations. Five patients with torsion dystonia had normal biopterin concentrations.

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai N., Narisawa K., Hayakawa H., Tada K. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics. 1982 Sep;70(3):426–430. [PubMed] [Google Scholar]
  2. Danks D. M., Bartholomé K., Clayton B. E., Curtius H., Gröbe H., Kaufman S., Leeming R., Pfleiderer W., Rembold H., Rey F. Malignant hyperphenylalaninaemia--current status (June 1977). J Inherit Metab Dis. 1978;1(2):49–53. doi: 10.1007/BF01801843. [DOI] [PubMed] [Google Scholar]
  3. Fukushima T., Nixon J. C. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem. 1980 Feb;102(1):176–188. doi: 10.1016/0003-2697(80)90336-x. [DOI] [PubMed] [Google Scholar]
  4. Harpey J. P. Les défauts de synthèse des bioptérines: les déficits complets (réductase et synthétase). Arch Fr Pediatr. 1983;40 (Suppl 1):231–235. [PubMed] [Google Scholar]
  5. Kaufman S., Holtzman N. A., Milstien S., Butler L. J., Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med. 1975 Oct 16;293(16):785–790. doi: 10.1056/NEJM197510162931601. [DOI] [PubMed] [Google Scholar]
  6. Kaufman S., Kapatos G., McInnes R. R., Schulman J. D., Rizzo W. B. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Pediatrics. 1982 Sep;70(3):376–380. [PubMed] [Google Scholar]
  7. Leeming R. J., Barford P. A., Blair J. A., Smith I. Blood spots on Guthrie cards can be used for inherited tetrahydrobiopterin deficiency screening in hyperphenylalaninaemic infants. Arch Dis Child. 1984 Jan;59(1):58–61. doi: 10.1136/adc.59.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Leeming R. J., Blair J. A., Green A., Raine D. N. Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan. Arch Dis Child. 1976 Oct;51(10):771–777. doi: 10.1136/adc.51.10.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leeming R. J., Blair J. A. The effects of pathological and normal physiological processes on biopterin derivative levels in man. Clin Chim Acta. 1980 Nov 20;108(1):103–111. doi: 10.1016/0009-8981(80)90298-3. [DOI] [PubMed] [Google Scholar]
  10. Lunte C. E., Kissinger P. T. Determination of pterins in biological samples by liquid chromatography/electrochemistry with a dual-electrode detector. Anal Chem. 1983 Aug;55(9):1458–1462. doi: 10.1021/ac00260a004. [DOI] [PubMed] [Google Scholar]
  11. Nagatsu T., Yamaguchi T., Kato T., Sugimoto T., Matsuura S., Akino M., Nagatsu I., Iizuka R., Narabayashi H. Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay. Clin Chim Acta. 1981 Feb 5;109(3):305–311. doi: 10.1016/0009-8981(81)90316-8. [DOI] [PubMed] [Google Scholar]
  12. Niederwieser A., Curtius H. C., Gitzelmann R., Otten A., Baerlocher K., Blehovà B., Berlow S., Gröbe H., Rey F., Schaub J. Excretion of pterins in phenylketonuria and phenylketonuria variants. Helv Paediatr Acta. 1980 Sep;35(4):335–342. [PubMed] [Google Scholar]
  13. Rey F., Saudubray J. M., Leeming R. J., Niederwieser A., Curtius H. C., Rey J. Les déficits partiels en tétrahydrobioptérine. Arch Fr Pediatr. 1983;40 (Suppl 1):237–241. [PubMed] [Google Scholar]
  14. Seifert W. E., Jr, Foxx J. L., Butler I. J. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Ann Neurol. 1980 Jul;8(1):38–42. doi: 10.1002/ana.410080106. [DOI] [PubMed] [Google Scholar]
  15. Smith I., Clayton B. E., Wolff O. H. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet. 1975 May 17;1(7916):1108–1111. doi: 10.1016/s0140-6736(75)92498-8. [DOI] [PubMed] [Google Scholar]
  16. Smith I., Hyland K., Kendall B. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency. J Inherit Metab Dis. 1985;8 (Suppl 1):39–45. doi: 10.1007/BF01800658. [DOI] [PubMed] [Google Scholar]
  17. Williams A. C., Levine R. A., Chase T. N., Lovenberg W., Calne D. B. CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):735–738. doi: 10.1136/jnnp.43.8.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Williams A., Eldridge R., Levine R., Lovenberg W., Paulson G. Low CSF hydroxylase cofactor (tetrahydrobiopterin) levels in inherited dystonia. Lancet. 1979 Aug 25;2(8139):410–411. doi: 10.1016/s0140-6736(79)90419-7. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES